- Reaction score
- 62
Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis
Conclusions and relevance: Available toxicity information from clinical trials of finasteride in men with Androgenetic Alopecia is very limited, is of poor quality, and seems to be systematically biased. In a cohort of men prescribed finasteride for routine treatment of Androgenetic Alopecia, most would have been excluded from the pivotal studies that supported US Food and Drug Administration approval for Androgenetic Alopecia. Published reports of clinical trials provide insufficient information to establish the safety profile for finasteride in the treatment of Androgenetic Alopecia.
Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis - PubMed
Available toxicity information from clinical trials of finasteride in men with Androgenetic Alopecia is very limited, is of poor quality, and seems to be systematically biased. In a cohort of men prescribed finasteride for routine treatment of Androgenetic Alopecia, most would have been excluded from the pivotal studies that...pubmed.ncbi.nlm.nih.gov
Hell, even Merck themselves admit not knowing what the long term effects are for younger men in their official FDA approval letter:
We need more studies, especially with younger men and long term, atleast 5+ years. Also done by endocrinologists, urologists and not some dermatologists who have a conflict of interest when it comes to fina.
That said, I still think everyone should be free to take what they want. Even if they succeed in banning fina for hairloss, people will get it through unofficial channels instead.
Just going to drop this here to avoid having the same discussion in two different threads.
Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis
Conclusions and relevance: Available toxicity information from clinical trials of finasteride in men with Androgenetic Alopecia is very limited, is of poor quality, and seems to be systematically biased. In a cohort of men prescribed finasteride for routine treatment of Androgenetic Alopecia, most would have been excluded from the pivotal studies that supported US Food and Drug Administration approval for Androgenetic Alopecia. Published reports of clinical trials provide insufficient information to establish the safety profile for finasteride in the treatment of Androgenetic Alopecia.
Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis - PubMed
Available toxicity information from clinical trials of finasteride in men with Androgenetic Alopecia is very limited, is of poor quality, and seems to be systematically biased. In a cohort of men prescribed finasteride for routine treatment of Androgenetic Alopecia, most would have been excluded from the pivotal studies that...pubmed.ncbi.nlm.nih.gov
Hell, even Merck themselves admit not knowing what the long term effects are for younger men in their official FDA approval letter:
We need more studies, especially with younger men and long term, atleast 5+ years. Also done by endocrinologists, urologists and not some dermatologists who have a conflict of interest when it comes to fina.
That said, I still think everyone should be free to take what they want. Even if they succeed in banning fina for hairloss, people will get it through unofficial channels instead.
I think pretty much everyone can agree on this (bolded).
Claims here are frequently made like "you're inhibiting the second most important androgen in the body, how could you not experience side effects" or "look at all of these neurosteroids that are inhibited, most people will get side effects from this at some point".
The issue is that the outcome data we have relating to human finasteride usage does not support these claims. All of the studies indicate a relatively low side effect profile. The studies funded by the PFS foundation may lay the ground work for future areas of research, but they can't be used to make inference about the population of finasteride users because they suffer from extreme selection bias (IE, sampling finasteride users who already complained about persistent side effects).
I'm personally not a huge fan of finasteride either; I'd really rather not inhibit a significant portion of my DHT and neurosteroid production. With that said, the majority of people that take the medication seem to do so without issue, and I'll continue to do so until I experience side effects or a better alternative comes out (IE, pyrilutamide if it is successful).